104 related articles for article (PubMed ID: 23787496)
1. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum tumor markers in various pathologic subtypes of gastric cancer.
Pang C; Ma Y; Shi W; Zi M; Chen J; Liang C; Li X; Liu Z; Du Y
J Gastrointest Surg; 2024 May; 28(5):694-702. PubMed ID: 38458911
[TBL] [Abstract][Full Text] [Related]
3. Value of combined serum CEA, CA72-4, and CA19-9 marker detection in diagnosis of colorectal cancer.
Kildusiene I; Dulskas A; Smailyte G
Tech Coloproctol; 2024 Feb; 28(1):33. PubMed ID: 38358422
[TBL] [Abstract][Full Text] [Related]
4. CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy.
Ma X; Zhou X; Guo J; Feng X; Zhao M; Zhang P; Zhang C; Gong S; Wu N; Zhang Y; Zhang X; Ren Z; Zhang P
BMC Surg; 2024 Jan; 24(1):31. PubMed ID: 38263014
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma.
Chen Z; Wang Y; Fang M
Cancer Med; 2020 Feb; 9(4):1392-1399. PubMed ID: 31881123
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers as a diagnostic key for hilar cholangiocarcinoma.
Juntermanns B; Radunz S; Heuer M; Hertel S; Reis H; Neuhaus JP; Vernadakis S; Trarbach T; Paul A; Kaiser GM
Eur J Med Res; 2010 Aug; 15(8):357-61. PubMed ID: 20947473
[TBL] [Abstract][Full Text] [Related]
7. Predicting Peritoneal Carcinomatosis in Locally Advanced Gastric Cancer: The Significance of Tumor Markers in the Peritoneal Washing.
Pinheiro JL; Duarte L; Santos AJ; Tojal A; Canhoto C; Ferreira M; Marques C; Pereira J
J Gastrointest Cancer; 2024 Mar; 55(1):427-434. PubMed ID: 37966631
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
9. Preoperatively predicting the lymph node metastasis and prognosis for gastric cancer patients.
Wang D; Wang Y; Dong L; Zhang X; Du J
Sci Rep; 2024 May; 14(1):11213. PubMed ID: 38755185
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma.
Hwang GI; Yoo CH; Sohn BH; Shin JH; Park YL; Kim HD; Kim YS; Han WK; Pae WK
Cancer Res Treat; 2004 Jun; 36(3):178-81. PubMed ID: 20396541
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer.
Zhou CM; Zhao SH
World J Gastrointest Oncol; 2024 May; 16(5):1737-1744. PubMed ID: 38764828
[TBL] [Abstract][Full Text] [Related]
12. Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.
Zhang B; Chen JY; Chen DD; Wang GB; Shen P
World J Gastroenterol; 2004 Jun; 10(11):1643-6. PubMed ID: 15162541
[TBL] [Abstract][Full Text] [Related]
13. Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.
Pan Q; Law COK; Yung MMH; Han KC; Pon YL; Lau TCK
PLoS One; 2018; 13(10):e0198980. PubMed ID: 30303958
[TBL] [Abstract][Full Text] [Related]
14. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
15. Unusually high serum CA19.9 in gastric carcinoma: A case report.
Thakur V; Mukherjee U
Indian J Clin Biochem; 2008 Jan; 23(1):100-2. PubMed ID: 23105733
[TBL] [Abstract][Full Text] [Related]
16. PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China.
Qu BG; Bi WM; Qu BT; Qu T; Han XH; Wang H; Liu YX; Jia YG
Medicine (Baltimore); 2016 Apr; 95(15):e3399. PubMed ID: 27082614
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH
Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453
[TBL] [Abstract][Full Text] [Related]
18. Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.
Kawada J; Saito T; Kurokawa Y; Kawabata R; Takeno A; Takeoka T; Nose Y; Wada H; Eguchi H; Doki Y;
Ann Gastroenterol Surg; 2024 Mar; 8(2):243-250. PubMed ID: 38455491
[TBL] [Abstract][Full Text] [Related]
19. A novel tRNA-derived fragment tRF-17-18VBY9M works as a potential diagnostic biomarker for gastric cancer.
Mao C; Zhang Z; Fang R; Yuan W; Wu Y; Cong H
J Cancer Res Clin Oncol; 2024 May; 150(5):263. PubMed ID: 38767702
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants.
Ogoshi K; Miyaji M; Nakamura K; Kondoh Y; Makuuchi H; Tajima T
Cancer Immunol Immunother; 1998 Mar; 46(1):14-20. PubMed ID: 9520287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
